Matches in Wikidata for { <http://www.wikidata.org/entity/Q27023414> ?p ?o ?g. }
- Q27023414 description "2014 nî lūn-bûn" @default.
- Q27023414 description "2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած" @default.
- Q27023414 description "2014 թվականի նոյեմբերին հրատարակված գիտական հոդված" @default.
- Q27023414 description "2014年の論文" @default.
- Q27023414 description "2014年論文" @default.
- Q27023414 description "2014年論文" @default.
- Q27023414 description "2014年論文" @default.
- Q27023414 description "2014年論文" @default.
- Q27023414 description "2014年論文" @default.
- Q27023414 description "2014年论文" @default.
- Q27023414 description "2014年论文" @default.
- Q27023414 description "2014年论文" @default.
- Q27023414 description "2014年论文" @default.
- Q27023414 description "2014年论文" @default.
- Q27023414 description "2014年论文" @default.
- Q27023414 description "2014년 논문" @default.
- Q27023414 description "article científic" @default.
- Q27023414 description "article scientific" @default.
- Q27023414 description "article scientifique (publié 2014-11)" @default.
- Q27023414 description "articol științific" @default.
- Q27023414 description "articolo scientifico (pubblicato il 2014-11)" @default.
- Q27023414 description "artigo científico (publicado na 2014)" @default.
- Q27023414 description "artigo científico (publicado na 2014-11)" @default.
- Q27023414 description "artigo científico" @default.
- Q27023414 description "artikull shkencor" @default.
- Q27023414 description "artikulong pang-agham" @default.
- Q27023414 description "artykuł naukowy" @default.
- Q27023414 description "artículo científico publicado en 2014" @default.
- Q27023414 description "artículu científicu espublizáu en 2014" @default.
- Q27023414 description "bilimsel makale" @default.
- Q27023414 description "bài báo khoa học" @default.
- Q27023414 description "mokslinis straipsnis" @default.
- Q27023414 description "naučni članak" @default.
- Q27023414 description "scienca artikolo" @default.
- Q27023414 description "scientific article" @default.
- Q27023414 description "teaduslik artikkel" @default.
- Q27023414 description "tieteellinen artikkeli" @default.
- Q27023414 description "tudományos cikk" @default.
- Q27023414 description "vedecký článok (publikovaný 2014-11)" @default.
- Q27023414 description "vetenskaplig artikel" @default.
- Q27023414 description "videnskabelig artikel (udgivet 2014-11)" @default.
- Q27023414 description "vitenskapelig artikkel" @default.
- Q27023414 description "vitskapeleg artikkel" @default.
- Q27023414 description "vědecký článek publikovaný v roce 2014" @default.
- Q27023414 description "wetenschappelijk artikel (gepubliceerd op 2014-11)" @default.
- Q27023414 description "wissenschaftlicher Artikel" @default.
- Q27023414 description "επιστημονικό άρθρο" @default.
- Q27023414 description "мақолаи илмӣ" @default.
- Q27023414 description "мақолаи илмӣ" @default.
- Q27023414 description "наукова стаття, опублікована в листопаді 2014" @default.
- Q27023414 description "научна статия" @default.
- Q27023414 description "научная статья" @default.
- Q27023414 description "научни чланак" @default.
- Q27023414 description "научни чланак" @default.
- Q27023414 description "מאמר מדעי" @default.
- Q27023414 description "سائنسی مضمون" @default.
- Q27023414 description "مقالة علمية (نشرت في نوفمبر 2014)" @default.
- Q27023414 description "مقالهٔ علمی" @default.
- Q27023414 description "২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q27023414 description "บทความทางวิทยาศาสตร์" @default.
- Q27023414 description "სამეცნიერო სტატია" @default.
- Q27023414 name "Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials" @default.
- Q27023414 name "Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials" @default.
- Q27023414 name "Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials" @default.
- Q27023414 type Item @default.
- Q27023414 label "Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials" @default.
- Q27023414 label "Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials" @default.
- Q27023414 label "Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials" @default.
- Q27023414 prefLabel "Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials" @default.
- Q27023414 prefLabel "Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials" @default.
- Q27023414 prefLabel "Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials" @default.
- Q27023414 P1433 Q27023414-8487BA96-331E-46A5-BE92-89848E75E08C @default.
- Q27023414 P1476 Q27023414-E45B2C7E-F142-4F01-A227-49A0142A740F @default.
- Q27023414 P2093 Q27023414-917AA87F-F7C6-421D-B85D-4DF24566D3C7 @default.
- Q27023414 P2093 Q27023414-A77C98C6-FF6B-43FE-9B82-C574616B960E @default.
- Q27023414 P2093 Q27023414-C8A7620D-9613-4294-94CA-3F4288E95680 @default.
- Q27023414 P304 Q27023414-7196FB0C-5664-4465-B039-978257A15640 @default.
- Q27023414 P31 Q27023414-10E871EB-47F3-49DD-9F33-B1BB45DAF377 @default.
- Q27023414 P31 Q27023414-D0182DB7-04E6-4189-A2B5-352624AE710E @default.
- Q27023414 P31 Q27023414-FFD6AB2C-2C73-4B1E-AA93-EC0EEAC13F1B @default.
- Q27023414 P3181 Q27023414-AFBB3CDF-1C22-47E5-871A-8C2A6815D0A1 @default.
- Q27023414 P356 Q27023414-7FE86D2E-3D46-40B4-8611-AAD7BA37170F @default.
- Q27023414 P407 Q27023414-0063C255-6ADF-4800-A2D6-8F29CFCFD7F0 @default.
- Q27023414 P433 Q27023414-6AE33346-67AA-47E4-9CCC-2F02E58EDE2E @default.
- Q27023414 P478 Q27023414-505A7A13-8FA5-44AF-BCB4-3D57A4A72201 @default.
- Q27023414 P577 Q27023414-F755DF3D-5FE2-4C4C-8310-F1C298E73A6F @default.
- Q27023414 P5875 Q27023414-9D4B8D5F-274C-40FF-B2DA-07D8B95FC810 @default.
- Q27023414 P698 Q27023414-C9E691D2-B8CB-4CF9-8B2B-D0E73E4AEB06 @default.
- Q27023414 P921 Q27023414-3C257AD7-0ABC-4DD6-B4D6-181259DF7FE7 @default.
- Q27023414 P921 Q27023414-5A7182BF-B641-4DC5-83D8-F9E1011E5564 @default.
- Q27023414 P921 Q27023414-769DD75A-57BD-4256-9AEC-BA01B6F4DE50 @default.
- Q27023414 P921 Q27023414-9AFFE011-FE3B-4FE9-97EF-41C053DCC3CD @default.
- Q27023414 P921 Q27023414-AE6554B4-658D-4E88-8912-D0E38CFD11D7 @default.
- Q27023414 P921 Q27023414-B2016812-0055-41EF-BE4F-26164CD4D692 @default.
- Q27023414 P921 Q27023414-C84D78DF-40CF-4B74-BC11-B182DCCA8892 @default.
- Q27023414 P3181 4326932 @default.
- Q27023414 P356 J.EJVS.2014.05.001 @default.
- Q27023414 P698 24951377 @default.
- Q27023414 P1433 Q15757064 @default.
- Q27023414 P1476 "Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials" @default.